DSGN: Design Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | Fell below 5% | Point72 Asset Management, L.P. | 3.80% | SEC | |
| 2026-08-14 | New 13G stake | Sirenia Capital Management LP | 9.50% | SEC |
Institutional ownership (Q2 2026)
136 institutions reported holding $618.22M of Design Therapeutics, Inc. on Form 13F (125 the quarter before). 27 opened a new position and 16 sold out. Shares held by institutions: +14%.
| Largest holders | Shares | Value |
|---|---|---|
| SR One Capital Management, LP | 6,526,476 | $94.44M |
| Logos Global Management LP | 3,000,000 | $43.41M |
| BAKER BROS. ADVISORS LP | 2,678,430 | $38.76M |
| Driehaus Capital Management LLC | 2,661,115 | $38.51M |
| BlackRock, Inc. | 2,660,024 | $38.49M |
| Point72 Asset Management, L.P. | 2,366,453 | $34.24M |
| Trails Edge Capital Partners, LP | 2,001,282 | $28.96M |
| Frazier Life Sciences Management, L.P. | 1,809,854 | $26.19M |
| Vivo Capital, LLC | 1,612,903 | $23.34M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,571,022 | $22.73M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.